Delivery Order SPE2DB20D1109-SPE2DB24FP65T

Award Date 8/6/24
Potential Completion Date 8/7/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,127.36 firm fixed-price delivery order is for the supply of 4,567,461,943 units of Pantoprazole Sodium Delayed-Release 40 mg tablets, a medication used for the treatment of various gastrointestinal conditions. The contract has an ultimate completion date of March 5, 2025. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,589.59 firm fixed-price delivery order is for the supply of 4,562,698,218 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has a completion date of November 6, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,233.77 firm fixed-price delivery order is for the supply of 4,566,894 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract has an ultimate completion date of January 13, 2025 and is not designated under any set-aside requirements, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,515.78 firm fixed-price delivery order is for the supply of 4,564,327,287 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets. The contract has an ultimate completion date of April 19, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,372.66 firm fixed-price delivery order contract is for the supply of 4,565,377,081 units of pantoprazole sodium delayed-release 40 mg tablets. The award has an ultimate completion date of August 8, 2024 and was not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,420.47, is a delivery order for the supply of 4,566,964,601 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract has an ultimate completion date of January 17, 2025, and uses a firm-fixed-price pricing structure. The contract is not designated as a set-aside....
This federal contract award, valued at $1,005.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,517,461 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets, with a completion date of November 22, 2024. The contract is a Delivery Order, with a Firm Fixed Price pricing type. It is not designated with any set-aside requirements, indicating open...
This federal contract award, with ID SPE2DB20D1004|SPE2DB23FF0H6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,111.76 firm fixed price delivery order is for the supply of 4,559,476,715 units of Pantoprazole Sodium Delayed-Release 40 mg tablets. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,593.69 firm fixed-price delivery order is for the supply of pantoprazole sodium delayed-release 40 mg tablets in 1,000-count bottles. The contract has an ultimate completion date of August 14, 2024 and was awarded on August 13, 2024. This delivery order is part of a larger $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,418.97 firm fixed-price delivery order is for the supply of 90-count bottles of pantoprazole sodium delayed-release 20 mg tablets. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which covers a broad range of...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FP65T
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,773.96 Firm Fixed Price Delivery Order contract is for the supply of 4,565,366 units of Pantoprazole Sodium Delayed-Release 40 mg Tablets.

The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

In addition to the DLA contract, AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 11:37 AM